Printer Friendly

Browse Rimonabant topic


1-16 out of 16 article(s)
Title Author Type Date Words
Medical cannabis: What practitioners need to know. van Rensburg, R.; Lorente, V.Pillay-Fuentes; Blockman, M.; Moodley, K.; Wilmshurst, J.M.; Decloedt, Mar 1, 2020 5245
Cannabidiol (CBD) for schizophrenia: Promise or pipe dream? The evidence is mixed, and the benefits are uncertain. Pierre, Joseph M. May 1, 2019 3633
Alert issued over e-liquids with undeclared drugs. Feb 1, 2019 191
Accuracy of Patient Opioid Use Reporting at the Time of Medical Cannabis License Renewal. Vigil, Jacob M.; Stith, Sarah S.; Reeve, Anthony P. Jan 1, 2018 2011
Rimonabant improves metabolic parameters partially attributed to restoration of high voltage-activated [Ca.sup.2+] channels in skeletal muscle in HFD-fed mice. Chen, B.; Hu, N. Report Jun 1, 2017 4130
Mecanismos neuroprotectores de los canabinoides en la isquemia cerebral y las enfermedades neurodegenerativas. Osuna-Zazueta, Marcela Amparo; Ponce-Gomez, Juan Antonio; Perez-Neri, Ivan Jun 1, 2015 6626
Terminated rimonabant trial shows signs of suicide risk. Splete, Heidi Report Sep 1, 2010 630
Risk of suicide spurs rimonabant trial to end. Splete, Heidi Sep 1, 2010 646
Sanofi cancels all trials of Acomplia obesity drug. Brief article Nov 10, 2008 228
Rimonabant application voluntarily withdrawn. Hackett, Catherine Brief article Jul 15, 2007 260
Rimonabant's FDA application pulled after panel meeting. Hackett, Catherine Brief article Jul 15, 2007 306
Citing safety, FDA panel advises against Zimulti approval. Ault, Alicia Jul 1, 2007 858
Panel votes down rimonabant on safety concerns. Ault, Alicia Jul 1, 2007 944
Sweet news for diabetics and fatties. Bateman, Chris Brief article Feb 1, 2007 150
Rimonabant cut Hb[A.sub.1c] in type 2 diabetic patients. Bell, John R. Jan 1, 2007 665
Rimonabant cuts [HbA.sub.1c], weight in type 2. Bell, John R. Clinical report Dec 15, 2006 673

Terms of use | Privacy policy | Copyright © 2020 Farlex, Inc. | Feedback | For webmasters